The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
Shi Zhengli, a leading virologist, became known as “Bat Woman” for her work on coronaviruses. She has spent decades studying ...
Between April 2020 and December 2022, over 535,000 people in Germany downloaded and activated the Corona Data Donation App ...
When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...
More than half of those who died were over the age of 65. There was a second, much smaller outbreak of SARS in 2004, linked to a medical lab in China. It probably occurred as a result of direct ...
What causes long Covid? Scientists don't fully understand why some develop disabling chronic complications after recovering ...
Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from ...